Programmes

The following Programme contains Metadata about the WES assays done with samples from the GLASS-NL, Young-Boost, PETAL and PERFECT cohorts, in addition to the CAIRO2, and CRITICS D1/D2 Clinical Trials.

This programme includes multi-omics projects to delineate aging related mechanims through systems biology approaches.

This is a demo programme.

Biorefineries are set to become an important agent in the shift towards a circular economy due to their potential to valorize organic wastes into marketable products. Anaerobic fermentations yielding volatile fatty acids (VFA) are a key process in this biorefinery paradigm as VFA act as intermediates between the organic wastes and the final biorefinery products. However, the development of a new bioprocess based on mixed-culture fermentation is an extremely challenging task. Targeting the desired ...

Chronic non-healing skin ulcers are a source of considerable suffering worldwide, particularly in rapidly growing aging populations. Why skin becomes fragile and heals poorly as we age remains unclear, although current research indicates that a major reason may reside in defective “stem cells” in skin that normally fuel its renewal and regeneration in order to maintain healthful and youthful function and appearance. Our findings indicate that stem cell pathways involving cell metabolism, DNA ...

Biomedizinische Informatik und Data Science

Creative Biolabs has developed proprietary procedures for Hi-Affi™ recombinant antibody production, with optimized library construction and screening processes using hybridoma or phage display technology.

This Programme is created as a repository for the Virtual Human Platform for Safety Assessment (VHP4Safety) project.

The recent COVID19 pandemic infection has undisclosed long-standing issues in the translation of drugs from animals to humans or vice-versa. Nearly 75% of emerging human infections worldwide originated from animals; existing drugs for human and animal (H&A) vector-borne diseases (VBD) are scarce, with limited efficacy, toxicity, and finite resources. Emerging environmental problems in pharmaceutical use/manufacturing increase attention in the field. The two drug pipelines are developed ...